THE NEW PATIENT INSTITUTE Trademark

Trademark Overview


On Friday, December 6, 2024, a trademark application was filed for THE NEW PATIENT INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the THE NEW PATIENT INSTITUTE trademark a serial number of 98889192. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, December 6, 2024. This trademark is owned by Scheduling Institute, Inc.. The THE NEW PATIENT INSTITUTE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting for professionals in connection with the scheduling of new and existing patients and customers
the new patient institute

General Information


Serial Number98889192
Word MarkTHE NEW PATIENT INSTITUTE
Filing DateFriday, December 6, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, December 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the words THE NEW PATIENT INSTITUTE and two greater than symbols in bold to the left of the words.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness consulting for professionals in connection with the scheduling of new and existing patients and customers

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, December 6, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameScheduling Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30005

Trademark Events


Event DateEvent Description
Friday, December 6, 2024NEW APPLICATION ENTERED